NEMA HEALTH
Live / Applied — Non-final action written — not yet mailed (as of 12 Mar 2026)
What this means for you
Not registered yet, but its 23 Oct 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79438311
- Mark type
- Stylized text
- Filed
- 23 Oct 2025
Goods and services
- Class 005 — Pharmaceuticals: Anticancer drugs; anticancer preparations; pharmaceutical products; chemico-pharmaceutical products; regenerative tissue [pharmaceutical preparations]; bacteriological preparations for pharmaceutical use; synthetic peptides for pharmaceutical use; chemical preparations for pharmaceutical use; chemical products for pharmaceutical purposes; pharmaceutical preparations containing stem cells; pharmaceutical products for cancer treatment; transdermal patches for administering pharmaceutical products; filled syringes for medical purposes containing pharmaceuticals; medical products; cells for medical use; diagnostic preparations for medical use in medical laboratories; immunoassay reagents for medical use; reagents with biomarkers for medical diagnostics; diagnostic preparations for medical use; diagnostic substances for medical use; diagnostic preparations and materials for medical and veterinary use; hygienic preparations for medical use.
- Class 042 — Scientific and technological services: Scientific research; biotechnological research; biochemical research; biological research, clinical research and medical research; genetic research; chemical research; research services; pharmaceutical research and development; scientific research and development; consultancy regarding pharmaceutical research; scientific analysis and research services; research in the field of nanobiotechnology; medical and pharmacological research services; research and development of pharmaceutical preparations for treating malignant tumors; consultancy relating to pharmaceutical research and development; research in the field of pharmacogenetics; information on scientific research in the field of biochemistry and biotechnology; research and development services in immunology; research in the field of immunodeficiency; scientific and technological design; scientific design services; scientific and technological services; scientific testing services; scientific research for medical purposes; consulting in the field of scientific research; technological and scientific services; scientific laboratory services; research in the field of genetic diseases; medical research in the field of rare diseases; research in the field of gene therapies; advisory services relating to gene therapy research.
Owner
- Nema Health S.L., ES
Prosecution history
- 13 Mar 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 12 Mar 2026 — NON-FINAL ACTION WRITTEN
- 10 Mar 2026 — ASSIGNED TO EXAMINER
- 05 Dec 2025 — APPLICATION FILING RECEIPT MAILED
- 05 Dec 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 04 Dec 2025 — SN ASSIGNED FOR SECT 66A APPL FROM IB